Pages
- (Senior) Clinical Scientist
- About Us
- About Vancouver City
- Aquinox Pharmaceuticals Prices Initial Public Offering
- Aquinox Privacy Policy
- Aquinox, Cardiome Raising B.C.’s Profile Among Biotech Investors
- AQX-1125
- Associate Director, Clinical Operations
- Atopic Dermatitis
- Big Pharma Venture Firms Pitch in to $18M Round for Phase 2 Anti-inflammatory Drug Developer
- Bladder Health Month – Spotlight on IC
- Bladder Pain Syndrome / Interstitial Cystitis
- Board of Directors
- Caverta from Canada – Sildenafil Citrate Tablets 50/100mg
- Cheap Dapoxetine (Priligy Generic)
- Chronic Obstructive Pulmonary Disease
- Contacts
- Corporate Presentation
- Corporate Profile
- Current Opportunities
- Director, Biostatistics
- Director, Clinical Operations
- Discovery Platform
- Facilities Coordinator
- Generalist, Human Resources
- Generic Viagra Price
- Home
- How to Apply
- Is Levitra Right for Me? Generic Levitra
- Ivermectin Oral Tablets
- Management
- Media Coverage
- Our Investors
- Partners and Collaborators
- Pipeline
- Pipeline / Product Platform
- Press Releases
- Project Coordinator, Medical Affairs
- Propecia Generic for Hair Loss (Finasteride Tablets)
- Sample Page
- Scientific & Clinical Meetings & Conferences
- Scientific Meetings & Conferences
- Scientist, Analytical Chemistry
- Scientist, Clinical Research
- Scientist, Translational Biology
- Selected Publications
- Senior Manager, Information Systems
- Senior Scientist, Clinical Research
- Senior Scientist, Clinical Research (Vancouver/San Bruno)
- SHIP1 and the PI3K Pathway
- SHIP1 and the PI3K Pathway
- Sitemap – Aqxpharma.com
- Technologist, Information Systems
- Technology
- The Inspiring Story
- Vancouver Biotech Company Catching Eye of Big Pharma
- Working at Aqx Canadian Pharmacy
Posts by category
- Category: Press Releases
- Aquinox Pharmaceuticals commences Phase 2 clinical trial of AQX-1125 in Chronic Obstructive Pulmonary Disease
- Aquinox Pharmaceuticals commences Phase II clinical trial of AQX-1125 in Bladder Pain Syndrome/Interstitial Cystitis
- Aquinox Pharmaceuticals Receives Regulatory Clearance to Initiate First Clinical Study of AQX-1125, A Novel Oral Anti-Inflammatory Compound
- Aquinox Pharmaceuticals Announces First Quarter 2014 Financial Results
- Aquinox Pharmaceuticals appoints Csaba Szabó, M.D., Ph.D., Vice President, Research and Chief Scientific Officer
- Aquinox Pharmaceuticals Initiates Two Phase IIa Clinical Studies in Airway Inflammation Following Successful Phase I
- Aquinox Pharmaceuticals Announces Closing of Initial Public Offering